This brand name is authorized in Albania, Austria, Ireland, Singapore, Tunisia
The drug BISOCOR contains one active pharmaceutical ingredient (API):
|
1
Bisoprolol hemifumarate
UNII UR59KN573L - BISOPROLOL FUMARATE
|
|
Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| BISOCOR Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07AB07 | Bisoprolol | C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AL | Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor | Identifier(s): 405/296 |
| Country: SG | Health Sciences Authority | Identifier(s): 15755P, 15805P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9343331, 9343332, 9343333 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
